TG Therapeutics, Inc.
(TGTX - NASDAQ)
35,59 USD
📋 Profilo Aziendale

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

|